ZANTE GREG bought VKTX
July 2, 2025 · Form 4 insider transaction
ZANTE GREG bought 7,667 shares of Viking Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,667
Price
$0.00
Total value
N/A
InsiderZANTE GREG
RoleOfficer
SecurityCommon Stock, par value $0.00001 per share
Transaction codeA: Grant or award
Transaction dateJuly 2, 2025
Filing dateJuly 3, 2025
Shares owned after172,926
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2025, 33.33% of which vested on July 2, 2025 upon the achievement of a non-financial performance goal.